Acasti Pharma Inc. (CVE:ACST – Get Free Report)’s share price shot up 1.8% during mid-day trading on Thursday . The company traded as high as C$0.58 and last traded at C$0.58. 2,450 shares were traded during mid-day trading, a decline of 63% from the average session volume of 6,576 shares. The stock had previously closed at C$0.57.
Acasti Pharma Stock Performance
The company has a debt-to-equity ratio of 0.52, a current ratio of 9.74 and a quick ratio of 9.41. The firm has a market capitalization of C$25.87 million, a PE ratio of -1.07 and a beta of 1.22. The company’s fifty day simple moving average is C$0.58 and its 200 day simple moving average is C$0.58.
Acasti Pharma Company Profile
Acasti Pharma Inc, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
Recommended Stories
- Five stocks we like better than Acasti Pharma
- NYSE Stocks Give Investors a Variety of Quality Options
- Micron Stock Under $100: Seize the AI-Driven Upside
- 3 Best Fintech Stocks for a Portfolio Boost
- AI’s Next Big Winners: 3 Small-Cap Stocks to Watch in 2025
- 10 Best Airline Stocks to Buy
- SolarEdge Stock Climbs Back: Goldman Sachs Sees 40% Upside
Receive News & Ratings for Acasti Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acasti Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
